Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,413.00
Bid: 1,413.00
Ask: 1,413.50
Change: 17.50 (1.25%)
Spread: 0.50 (0.035%)
Open: 1,392.00
High: 1,417.50
Low: 1,388.00
Prev. Close: 1,395.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

7 Jul 2025 11:00

US stocks weekly: Fireworks

Semiconductor index up nearly 2% ** Financials firm 2.4%. Big banks rise after Fed stress test success, clearing path for dividend hikes, share buybacks

Read more
3 Jul 2025 17:10

UK stocks stabilise a day after selloff on fiscal concerns

FTSE 100 rises 0.6%, FTSE 250 adds 1.2%

*

Read more
3 Jul 2025 16:58

LONDON MARKET CLOSE: Pound climbs, bond yields ease as PM backs Reeves

(Alliance News) - The FTSE 100 and sterling rallied, while the bond market calmed on Thursday as Keir Starmer supported his chancellor, reassuring markets that a change at the Treasury wasn't on the cards.

Read more
3 Jul 2025 16:44

UK dividends calendar - next 7 days

Read more
30 Jun 2025 17:28

UK's midcaps record best quarter in more than four years, blue-chip index down

FTSE 100 down 0.4%, FTSE 250 falls 0.4%

*

Read more
30 Jun 2025 09:38

LONDON BROKER RATINGS: Babcock International price targets raised

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
27 Jun 2025 20:47

US senator probes GSK's halt of children's asthma inhaler

Hassan says decision reduces access for low-income patients

*

Read more
25 Jun 2025 09:48

Bharat, GSK to halve price of malaria vaccine by 2028

Price to be cut to below $5 per dose by 2028

*

Read more
25 Jun 2025 08:00

Bharat, GSK to halve price of malaria vaccine by 2028

LONDON, June 25 (Reuters) - Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to $5 per dose by 2028, more than halving its current cost, they said on Wednesday.

Read more
23 Jun 2025 11:07

EMA accepts marketing authorisation application for GSK's linerixibat

(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its marketing authorisation application for linerixibat, an investigational treatment for cholestatic pruritus in patients with primary biliary cholangitis (PBC).

Read more
23 Jun 2025 09:55

GSK drug to treat itch caused by liver disease accepted for EU review

(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease.

Read more
20 Jun 2025 17:31

UK's FTSE 100 sees first weekly fall in six; Middle East tensions in focus

FTSE 100 down 0.2%, FTSE 250 adds 0.4%

*

Read more
20 Jun 2025 17:04

LONDON MARKET CLOSE: FTSE 100 underperforms Europe despite Iran talks

(Alliance News) - London's FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and drug stocks offset hopes for progress in the Israel-Iran conflict.

Read more
20 Jun 2025 08:27

Japan accepts GSK application for expanded use of RSV vaccine Arexvy

(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [RSV] vaccine Arexvy.

Read more
20 Jun 2025 07:19

GSK hoping to expand Arexvy usage in Japan

(Sharecast News) - Japanese regulators have accepted GSK's application to expand the use of its RSV vaccine, Arexvy, to the entire adult population.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.